🇮🇳IN
Sign In
SU

SUVEN

NSE

Suven Life Sciences Limited

₹261.20

-11.80(-4.32%)

Group Companies

Foreign Flows

sector level — not this stock
Healthcare sector+₹3 Crnet foreign buying
2026-09-16 to 2026-09-end

This is the flow into the whole Healthcare sector, not into SUVEN. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.

Supply Chain

suppliers and customers in the graph

Relationship Network

directors, institutions, group entities

Macro Sensitivity

rates, currency, commodities

Revenue by Segment

Business Group

Geographic Exposure

revenue, imports, currency

Scenario analysis

stated assumptions, shown workings

SUVEN exposure summary

Suven Life Sciences Limited reports a single business segment, The Company has only one business segment, i.e. Research & Development and does not operate in any other segments. Hence, segment reporting as per IND AS 108 (Operating Segment) is not presented. Suven Life Sciences Limited is a constituent of 2 indices.

Index memberships2

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer